Dr. Robert G. Hale Introduces First FDA-Approved KLS Martin Preprosthetic Device for Patients Where Traditional Dental Implants Have Failed

WOODLAND HILLS, Calif., Aug. 28, 2025 /PRNewswire/ — Dr. Robert G. Hale, a leading oral and maxillofacial surgeon, announced the introduction of the first FDA-approved device designed specifically to treat patients who are no longer candidates for traditional dental implants. The KLS Martin Preprosthetic provides a predictable, durable solution for individuals with edentulous ridge deformities or failed implant sites.

Patients who have been told they are not candidates for implants finally have a solution.

Until now, many patients with too little bone in the upper jaw (maxilla) or prior implant complications faced limited and often invasive alternatives such as extensive grafting, sinus lifts, or zygomatic implants. The KLS Martin Preprosthetic offers a groundbreaking option that can be placed in a minimally invasive procedure of approximately 90 minutes under procedural sedation, restoring function, comfort, and quality of life for patients previously told they had no viable path forward.

“Patients who have been told they are not candidates for implants finally have a solution,” said Dr. Robert G. Hale. “With the KLS Martin Preprosthetic, we can deliver a more predictable, efficient path to fixed teeth when traditional approaches have failed.”

As an early clinical researcher with the device, Dr. Hale is committed not only to patient care but also to elevation of the standard of care. He collaborates with KLS Martin and trains colleagues nationwide on this next-generation approach to implant dentistry.

The KLS Martin Preprosthetic has the potential to reshape implant dentistry by reducing complications, shortening treatment timelines, and offering an FDA-approved alternative when conventional implants are not possible.

For consultations and more information, visit www.RobertGHale.com.

About Dr. Robert G. Hale

Dr. Hale is an accomplished oral and maxillofacial surgeon recognized for pioneering work in advanced implant solutions. In addition to his clinical expertise, Dr. Hale brings decades of distinguished military service as a former Colonel in the United States Army Dental Corps. He has served in leadership roles at premier military medical centers, where he provided surgical care to service members and advanced research in maxillofacial reconstruction. Dr. Hale collaborates with leading medical device manufacturers to bring innovative, evidence-based technologies to patients, with a focus on predictable outcomes and patient comfort.

Media Contact:
Michael Stein
(818) 610-1092
pr@connectionmarketing.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/dr-robert-g-hale-introduces-first-fda-approved-kls-martin-preprosthetic-device-for-patients-where-traditional-dental-implants-have-failed-302540525.html

SOURCE Dr. Robert G. Hale

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

17 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

22 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

23 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

23 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

23 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago